| Source: |
| Type: |
| Cell Viability |
| 8097- | KAE, | The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells |
| - | in-vitro, | CRC, | LS174T |
| 8100- | KAE, | Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways |
| - | in-vitro, | Cerv, | HeLa |
| 8103- | KAE, | The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions |
| - | in-vitro, | HCC, | HUH7 |
| 8105- | KAE, | Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: A comprehensive review |
| - | Review, | Var, | NA |
| - | in-vitro, | Ovarian, | A2780S |
| 8059- | KAE, | Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway |
| - | in-vitro, | Cerv, | KB |
| 8064- | KAE, | Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | SNU-213 |
| 8065- | KAE, | Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | CRC, | HCT116 |
| 8075- | KAE, | QC, | Systematic review on anticancer potential of Kaempferol and quercetin against lung, breast, and colorectal cancers with emphasis on in vitro and in vivo studies |
| - | Review, | Var, | NA |
| 9002- | L-THE, | Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | AML, | K562 |
| 8121- | LA, | Exploring Anticancer Potential of Lactobacillus Strains: Insights into Cytotoxicity and Apoptotic Mechanisms on HCT 115 Cancer Cells |
| - | in-vitro, | CRC, | NA |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | HCC, | SK-HEP-1 |
| 8165- | LapC, | Lapachol interferes with the cell cycle and inhibits proliferation and migration of bladder tumor cells with effects on ncRNA expression |
| - | in-vitro, | Bladder, | RT4 |
| 8175- | Las, | Lasiodin Inhibits Proliferation of Human Nasopharyngeal Carcinoma Cells by Simultaneous Modulation of the Apaf-1/Caspase, AKT/MAPK and COX-2/NF-κB Signaling Pathways |
| - | in-vitro, | NPC, | NA |
| 8177- | Las, | Lasiokaurin Regulates PLK1 to Induce Breast Cancer Cell G2/M Phase Block and Apoptosis |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 8249- | LCA, | Induction of C/EBP homologous protein-mediated apoptosis and autophagy by licochalcone A in non-small cell lung cancer cells |
| - | in-vitro, | NSCLC, | NA |
| 8248- | LCA, | Licochalcone A Inhibits the Proliferation of Human Lung Cancer Cell Lines A549 and H460 by Inducing G2/M Cell Cycle Arrest and ER Stress |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | Lung, | H460 |
| 8241- | LCA, | Licochalcone A induces apoptotic cell death via JNK/p38 activation in human nasopharyngeal carcinoma cells |
| - | in-vitro, | NPC, | NA |
| 8253- | LCA, | Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinoma |
| - | in-vitro, | SCC, | HSC4 |
| 8260- | LCA, | Licochalcone A Induces Ferroptosis in Hepatocellular Carcinoma via Reactive Oxygen Species Activated by the SLC7A11/GPX4 Pathway |
| - | vitro+vivo, | Liver, | HepG2 | - | in-vitro, | Liver, | HUH7 |
| 8209- | LCA, | Licochalcone A Exerts Anti-Cancer Activity by Inhibiting STAT3 in SKOV3 Human Ovarian Cancer Cells |
| - | in-vitro, | Ovarian, | SKOV3 |
| 8208- | LCA, | Licochalcone A inhibits PI3K/Akt/mTOR signaling pathway activation and promotes autophagy in breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 8213- | LCA, | Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | H322 |
| 8210- | LCA, | Licochalcone A-Induced Human Bladder Cancer T24 Cells Apoptosis Triggered by Mitochondria Dysfunction and Endoplasmic Reticulum Stress |
| - | in-vitro, | Bladder, | T24/HTB-9 |
| 8211- | LCA, | Licochalcone A induces endoplasmic reticulum stress-mediated apoptosis of endometrial cancer cells via upregulation of GRP78 expression |
| - | in-vitro, | EC, | NA |
| 8287- | LE, | New insights into the antioxidant and apoptotic potential of Glycyrrhiza glabra L. during hydrogen peroxide mediated oxidative stress: An in vitro and in silico evaluation |
| - | in-vitro, | Nor, | NA |
| 8265- | LE, | Glycyrrhizin ameliorates colorectal cancer progression by regulating NHEJ pathway through inhibiting HMGB1-induced DNA damage response |
| - | vitro+vivo, | CRC, | NA |
| 8276- | LE, | Cisplatin, | Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis |
| - | in-vitro, | NSCLC, | NA |
| 8278- | LE, | Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology |
| - | Review, | Var, | NA |
| 8279- | LE, | 18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H23 | - | in-vitro, | Lung, | H460 |
| 8191- | LGE, | Lemongrass (Cymbopogon citratus (D.C.) Stapf) Presents Antitumoral Effect and Improves Chemotherapy Activity in Prostate Cancer Cells |
| - | in-vitro, | Pca, | DU145 |
| 8294- | lign, | Secoisolariciresinol diglucoside induces pyroptosis by activating caspase-1 to cleave GSDMD in colorectal cancer cells |
| - | vitro+vivo, | CRC, | LoVo | - | in-vitro, | CRC, | SW-620 | - | in-vitro, | NA, | SW480 | - | in-vitro, | CRC, | HT-29 | - | in-vitro, | CRC, | HCT116 |
| 8302- | lign, | The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth |
| - | vitro+vivo, | BC, | E0771 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 8330- | LIN, | SIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic death |
| - | in-vitro, | GBM, | U87MG |
| 8326- | LIN, | Linalool in cancer pharmacology: pharmacokinetic limitations and preclinical cytotoxic evidence for translational development |
| - | Review, | Var, | NA |
| 8325- | LIN, | Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular docking |
| - | in-vitro, | BC, | NA |
| 8321- | LIN, | doxoR, | Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells |
| - | in-vitro, | BC, | MCF7 |
| - | in-vitro, | Oral, | OECM-1 | - | in-vitro, | Nor, | FR-2 |
| 8386- | LT, | Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway |
| - | in-vitro, | ALL, | SUP-B15 |
| 8403- | LT, | Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells |
| - | in-vitro, | CRC, | HT-29 |
| 8402- | LT, | Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway |
| - | vitro+vivo, | CRC, | T24/HTB-9 |
| 8397- | LT, | Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules |
| - | Review, | Var, | NA |
| 8369- | LT, | Luteolin inhibits proliferation of lung cancer A549 cells by increasing ROS production and inhibiting the AKT/mTOR signaling pathway and HO-1 expression |
| - | in-vitro, | Lung, | A549 |
| 2910- | LT, | FA, | Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
| 2915- | LT, | Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | SNU-407 | - | in-vitro, | Nor, | FHC |
| 8345- | Lut, | Lutein inhibits breast cancer cell growth by suppressing antioxidant and cell survival signals and induces apoptosis |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 8342- | Lut, | Cisplatin, | Lutein Influences Cisplatin Sensitivity Through Differential Regulation of DNA Damage Response Genes in Breast Cancer Cells |
| - | in-vitro, | Nor, | HUVECs | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 8414- | Lyco, | Exploring the Therapeutic Potential of Lycopene: Mechanisms, Biological Activities, and Health Benefits |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 4777- | Lyco, | Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells |
| - | in-vitro, | GC, | AGS |
| 4779- | Lyco, | Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells |
| - | in-vitro, | PC, | PANC1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:897 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid